Basilea Pharmaceutica AG (BPMUF)
77.40
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Basilea Pharmaceutica Cash from Operations (TTM) : 75.01M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.01M |
| December 31, 2025 | 77.64M |
| June 30, 2025 | 91.89M |
| December 31, 2024 | 85.29M |
| June 30, 2024 | 11.54M |
| December 31, 2023 | 15.37M |
| June 30, 2023 | 31.13M |
| December 31, 2022 | 7.312M |
| June 30, 2022 | -5.134M |
| December 31, 2021 | -35.19M |
| June 30, 2021 | -52.88M |
| December 31, 2020 | -57.33M |
| June 30, 2020 | -53.03M |
| December 31, 2019 | -64.07M |
| June 30, 2019 | -64.36M |
| December 31, 2018 | -81.45M |
| June 30, 2018 | -5.415M |
| December 31, 2017 | 20.22M |
| June 30, 2017 | -58.39M |
| December 31, 2016 | -76.24M |
| June 30, 2016 | -104.23M |
| December 31, 2015 | -69.95M |
| Date | Value |
|---|---|
| June 30, 2015 | -48.69M |
| December 31, 2014 | -78.68M |
| June 30, 2014 | -78.49M |
| December 31, 2013 | -64.06M |
| June 30, 2013 | 170.84M |
| December 31, 2012 | 155.52M |
| June 30, 2012 | -102.58M |
| December 31, 2011 | -93.10M |
| June 30, 2011 | 48.45M |
| December 31, 2010 | 105.18M |
| June 30, 2010 | -29.44M |
| December 31, 2009 | -104.77M |
| June 30, 2009 | -114.82M |
| December 31, 2008 | -117.76M |
| June 30, 2008 | -106.82M |
| December 31, 2007 | -66.28M |
| June 30, 2007 | -54.08M |
| December 31, 2006 | -57.89M |
| June 30, 2006 | -47.99M |
| December 31, 2005 | 30.01M |
| June 30, 2005 | 19.93M |
| December 31, 2004 | -51.85M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Santhera Pharmaceuticals Holding AG | -43.47M |
| BeOne Medicines Ltd. | 1.488B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -369.58M |
| Idorsia Ltd. | -161.54M |